CIT can broadcast your seminar, conference or meeting live to a world-wide
audience over the Internet as a real-time streaming video. The event can
be recorded and made available for viewers to watch at their convenience
as an on-demand video or a downloadable podcast. CIT can also broadcast
NIH-only or HHS-only content.
Craig Thompson became the President and Chief Executive Officer of Memorial Sloan-Kettering Cancer Center - the world's oldest and largest private institution devoted to cancer prevention, treatment, research, and education - in November 2010. Dr. Thompson is a board-certified internist and medical oncologist with extensive research experience in cancer, immunology, and translational medicine. To date, Dr. Thompson has published more than 350 peer-reviewed manuscripts and more than 85 reviews. Currently, his laboratory undertakes basic research in the fields of cancer biology and immunology. His laboratory has recently contributed to the resurgent interest in cancer cell metabolism and is developing translational therapies to exploit the metabolic addictions exhibited by cancer cells.
Dr. Thompson is a member of the Institute of Medicine, the National Academy of Sciences, the American Academy of Arts and Sciences, and the Medical Advisory Board of the Howard Hughes Medical Institute.
The NIH Wednesday Afternoon Lecture Series includes weekly scientific talks by some of the top researchers in the biomedical sciences worldwide.
IDH mutations : oncometabolite deregulation of epigenetic remodeling [electronic resource] / Craig B. Thompson.
Series:
NIH Wednesday afternoon lecture (WALs)
Author:
Thompson, Craig. National Institutes of Health (U.S.)
Publisher:
[Bethesda, Md. : National Institutes of Health, 2012]
Other Title(s):
NIH Wednesday afternoon lecture (WALs)
Abstract:
(CIT): Craig Thompson became the President and Chief Executive Officer of Memorial Sloan-Kettering Cancer Center - the world's oldest and largest private institution devoted to cancer prevention, treatment, research, and education - in November 2010. Dr. Thompson is a board-certified internist and medical oncologist with extensive research experience in cancer, immunology, and translational medicine. To date, Dr. Thompson has published more than 350 peer-reviewed manuscripts and more than 85 reviews. Currently, his laboratory undertakes basic research in the fields of cancer biology and immunology. His laboratory has recently contributed to the resurgent interest in cancer cell metabolism and is developing translational therapies to exploit the metabolic addictions exhibited by cancer cells. Dr. Thompson is a member of the Institute of Medicine, the National Academy of Sciences, the American Academy of Arts and Sciences, and the Medical Advisory Board of the Howard Hughes Medical Institute.
